Wednesday, March 30, 2022

USFDA

 1) U.S. FDA approves UCB's drug for rare childhood epilepsy

source:https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-ucbs-drug-rare-childhood-epilepsy-2022-03-28/

2) STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

Source: https://www.businesswire.com/news/home/20220328005207/en/STAAR-Surgical-Announces-U.S.-FDA-Approval-of-EVO-Visian%C2%AE-Implantable-Collamer%C2%AE-Lenses

 3) Lupin receives  approval from USFDA for Sildenafil for oral suspension

Source:  https://www.indiainfoline.com/article/news-sector-pharma-healthcare/lupin-receives-approval-from-usfda-for-sildenafil-for-oral-suspension-122032800035_1.html